id CRUZ_cc0e449390f9d2b82c5afa0ca925275a
oai_identifier_str oai:www.arca.fiocruz.br:icict/57500
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Mitjà, OriolAlemany, AndreaMarks, MichaelLezama Mora, Jezer IRodríguez-Aldama, Juan CarlosSilva, Mayara Secco TorresCorral Herrera, Ever ArturoCrabtree-Ramirez, BrendaBlanco, José LuisGirometti, NicoloMazzotta, ValentinaHazra, AniruddhaSilva, MacarenaMontenegro-Idrogo, Juan JoséGebo, KellyGhosn, JadePeña Vázquez, María FernandaPrado, Eduardo MatosUnigwe, UcheVillar-García, JuditWald-Dickler, NoahZucker, JasonParedes, RogerCalmy, AlexandraWaters, LauraGalvan-Casas, CristinaWalmsley, SharonOrkin, Chloe M.2023-03-22T14:41:31Z2023-03-22T14:41:31Z2023MITJÀ, Oriol et al. Mpox in people with advanced HIV infection: a global case series. The Lancet, p. 1-11, 2023.0140-6736https://www.arca.fiocruz.br/handle/icict/5750010.1016/S0140-6736(23)00273-8engThe LancetVaríola dos macacosHIVInfecção por HIVMpoxHIVHIV infectionMpox in people with advanced HIV infection: a global case seriesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2023University Hospital Germans Trias i Pujol. Fight Infectious Diseases Foundation. Skin Neglected Tropical Diseases and Sexually Transmitted Infections section. Badalona, Spain.University Hospital Germans Trias i Pujol. Fight Infectious Diseases Foundation. Skin Neglected Tropical Diseases and Sexually Transmitted Infections section. Badalona, Spain.University Hospital Germans Trias i Pujol, Badalona, Spain / London School of Hygiene & Tropical Medicine Clinical Research Department. London, UK / University College London Hospitals. Hospital for Tropical Diseases, and Division of Infection and Immunity. London, UK.Clínica Especializada Condesa Cuauhtémoc. Mexico City, México.Clínica Especializada Condesa Iztapalapa. Mexico City, México.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Departamento de Infectología, México City, México.Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Departamento de Infectología, México City, México.Barcelona University. Hospital Clínic de Barcelona. Infectious Diseases Department. Barcelona, Spain / Instituto de Salud Carlos III. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas. Madrid, Spain / Institut d’Investigacions Mèdiques August Pi i Sunyer. Barcelona, Spain.Chelsea and Westminster Hospital NHS Foundation Trust. Department of HIV and Genitourinary Medicine. London, UK.National Institute for Infectious Disease Lazzaro Spallanzani. Rome, Italy.University of Chicago Medicine. Section of Infectious Diseases and Global Health. Chicago, IL, USA.Hospital San Borja Arriarán. Infectious Diseases Department. Santiago, Chile,Hospital Nacional Dos de Mayo. Infectious Diseases Department. Lima, Perú / Centro de Investigaciones Tecnológicas Biomédicas y Medioambientales. Lima, Perú.Johns Hopkins University School of Medicine. Division of Infectious Diseases, Baltimore, MD, USA.Assistance Publique - Hôpitaux de Paris Nord. Bichat University Hospital, Paris, France / Université Paris Cité. Centre of Research in Epidemiology and Statistics. INSERM UMR 1137 IAME. Paris, FranceHospital Enrique Garcés del Sur. Infectious Diseases Department. Quito, Ecuador.Hospital Nacional Arzobispo Loayza. Infectious Diseases Department. Lima, Perú.University of Nigeria Teaching Hospital. Infectious Disease Unit Department of Medicine. Enugu, Nigeria.Hospital del Mar. Infectious Disease Unit. Barcelona, Spain /Hospital del Mar Medical Research Institute. Infectious Diseases and Antibiotic Therapy Research Group. Barcelona, Spain.Los Angeles County and University of Southern California Medical Center. Los Angeles, CA, USA / University of Southern California. Keck School of Medicine. Los Angeles, CA, USA.Columbia University Irving Medical Center. Division of Infectious Diseases. New York, NY, USA.University Hospital Germans Trias i Pujol. Fight Infectious Diseases Foundation. Infectious Disease Department. Badalona, Spain.Geneva University Hospitals. Division of Infectious Diseases. HIV/AIDS Unit. Geneva, Switzerland.Central and North West London NHS Trust. London, UK.University Hospital Germans Trias i Pujol. Fight Infectious Diseases Foundation. Skin Neglected Tropical Diseases and Sexually Transmitted Infections section. Badalona, Spain / Hospital Universitario de Móstoles. Dermatology Department. Madrid, Spain.University Health Network. Toronto, Canada / University of Toronto. Toronto, Canada.Queen Mary University of London. London, UK / Barts Health NHS Trust. Department of Infection and Immunity. London, UK.Background: People living with HIV have accounted for 38–50% of those affected in the 2022 multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell counts and similar outcomes to those without HIV. Emerging data suggest worse clinical outcomes and higher mortality in people with more advanced HIV. We describe the clinical characteristics and outcomes of mpox in a cohort of people with HIV and low CD4 cell counts (CD4 <350 cells per mm³). Methods: A network of clinicians from 19 countries provided data of confirmed mpox cases between May 11, 2022, and Jan 18, 2023, in people with HIV infection. Contributing centres completed deidentified structured case report sheets to include variables of interest relevant to people living with HIV and to capture more severe outcomes. We restricted this series to include only adults older than 18 years living with HIV and with a CD4 cell count of less than 350 cells per mm³ or, in settings where a CD4 count was not always routinely available, an HIV infection clinically classified as US Centers for Disease Control and Prevention stage C. We describe their clinical presentation, complications, and causes of death. Analyses were descriptive. Findings: We included data of 382 cases: 367 cisgender men, four cisgender women, and ten transgender women. The median age of individuals included was 35 (IQR 30–43) years. At mpox diagnosis, 349 (91%) individuals were known to be living with HIV; 228 (65%) of 349 adherent to antiretroviral therapy (ART); 32 (8%) of 382 had a concurrent opportunistic illness. The median CD4 cell count was 211 (IQR 117–291) cells per mm³, with 85 (22%) individuals with CD4 cell counts of less than 100 cells per mm³ and 94 (25%) with 100–200 cells per mm³. Overall, 193 (51%) of 382 had undetectable viral load. Severe complications were more common in people with a CD4 cell count of less than 100 cells per mm³ than in those with more than 300 cells per mm³, including necrotising skin lesions (54% vs 7%), lung involvement (29% vs 0%) occasionally with nodules, and secondary infections and sepsis (44% vs 9%). Overall, 107 (28%) of 382 were hospitalised, of whom 27 (25%) died. All deaths occurred in people with CD4 counts of less than 200 cells per mm³. Among people with CD4 counts of less than 200 cells per mm³, more deaths occurred in those with high HIV viral load. An immune reconstitution inflammatory syndrome to mpox was suspected in 21 (25%) of 85 people initiated or re-initiated on ART, of whom 12 (57%) of 21 died. 62 (16%) of 382 received tecovirimat and seven (2%) received cidofovir or brincidofovir. Three individuals had laboratory confirmation of tecovirimat resistance. Interpretation: A severe necrotising form of mpox in the context of advanced immunosuppression appears to behave like an AIDS-defining condition, with a high prevalence of fulminant dermatological and systemic manifestations and death. Funding: None.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/57500/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALve_Mitjà_Oriol_etal_INI_2023.pdfve_Mitjà_Oriol_etal_INI_2023.pdfapplication/pdf3304269https://www.arca.fiocruz.br/bitstream/icict/57500/2/ve_Mitj%c3%a0_Oriol_etal_INI_2023.pdfbbfb1869bb1225f2e922fd6ba99fa1caMD52icict/575002023-03-24 19:44:18.664oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-24T22:44:18Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Mpox in people with advanced HIV infection: a global case series
title Mpox in people with advanced HIV infection: a global case series
spellingShingle Mpox in people with advanced HIV infection: a global case series
Mitjà, Oriol
Varíola dos macacos
HIV
Infecção por HIV
Mpox
HIV
HIV infection
title_short Mpox in people with advanced HIV infection: a global case series
title_full Mpox in people with advanced HIV infection: a global case series
title_fullStr Mpox in people with advanced HIV infection: a global case series
title_full_unstemmed Mpox in people with advanced HIV infection: a global case series
title_sort Mpox in people with advanced HIV infection: a global case series
author Mitjà, Oriol
author_facet Mitjà, Oriol
Alemany, Andrea
Marks, Michael
Lezama Mora, Jezer I
Rodríguez-Aldama, Juan Carlos
Silva, Mayara Secco Torres
Corral Herrera, Ever Arturo
Crabtree-Ramirez, Brenda
Blanco, José Luis
Girometti, Nicolo
Mazzotta, Valentina
Hazra, Aniruddha
Silva, Macarena
Montenegro-Idrogo, Juan José
Gebo, Kelly
Ghosn, Jade
Peña Vázquez, María Fernanda
Prado, Eduardo Matos
Unigwe, Uche
Villar-García, Judit
Wald-Dickler, Noah
Zucker, Jason
Paredes, Roger
Calmy, Alexandra
Waters, Laura
Galvan-Casas, Cristina
Walmsley, Sharon
Orkin, Chloe M.
author_role author
author2 Alemany, Andrea
Marks, Michael
Lezama Mora, Jezer I
Rodríguez-Aldama, Juan Carlos
Silva, Mayara Secco Torres
Corral Herrera, Ever Arturo
Crabtree-Ramirez, Brenda
Blanco, José Luis
Girometti, Nicolo
Mazzotta, Valentina
Hazra, Aniruddha
Silva, Macarena
Montenegro-Idrogo, Juan José
Gebo, Kelly
Ghosn, Jade
Peña Vázquez, María Fernanda
Prado, Eduardo Matos
Unigwe, Uche
Villar-García, Judit
Wald-Dickler, Noah
Zucker, Jason
Paredes, Roger
Calmy, Alexandra
Waters, Laura
Galvan-Casas, Cristina
Walmsley, Sharon
Orkin, Chloe M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Mitjà, Oriol
Alemany, Andrea
Marks, Michael
Lezama Mora, Jezer I
Rodríguez-Aldama, Juan Carlos
Silva, Mayara Secco Torres
Corral Herrera, Ever Arturo
Crabtree-Ramirez, Brenda
Blanco, José Luis
Girometti, Nicolo
Mazzotta, Valentina
Hazra, Aniruddha
Silva, Macarena
Montenegro-Idrogo, Juan José
Gebo, Kelly
Ghosn, Jade
Peña Vázquez, María Fernanda
Prado, Eduardo Matos
Unigwe, Uche
Villar-García, Judit
Wald-Dickler, Noah
Zucker, Jason
Paredes, Roger
Calmy, Alexandra
Waters, Laura
Galvan-Casas, Cristina
Walmsley, Sharon
Orkin, Chloe M.
dc.subject.other.en_US.fl_str_mv Varíola dos macacos
HIV
Infecção por HIV
topic Varíola dos macacos
HIV
Infecção por HIV
Mpox
HIV
HIV infection
dc.subject.en.en_US.fl_str_mv Mpox
HIV
HIV infection
description 2023
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-03-22T14:41:31Z
dc.date.available.fl_str_mv 2023-03-22T14:41:31Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv MITJÀ, Oriol et al. Mpox in people with advanced HIV infection: a global case series. The Lancet, p. 1-11, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/57500
dc.identifier.issn.en_US.fl_str_mv 0140-6736
dc.identifier.doi.none.fl_str_mv 10.1016/S0140-6736(23)00273-8
identifier_str_mv MITJÀ, Oriol et al. Mpox in people with advanced HIV infection: a global case series. The Lancet, p. 1-11, 2023.
0140-6736
10.1016/S0140-6736(23)00273-8
url https://www.arca.fiocruz.br/handle/icict/57500
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv The Lancet
publisher.none.fl_str_mv The Lancet
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/57500/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/57500/2/ve_Mitj%c3%a0_Oriol_etal_INI_2023.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
bbfb1869bb1225f2e922fd6ba99fa1ca
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008954337263616